Expression Level of GRK5 in Parkinson's Disease Α-Synuclein Transgenic Mice

Peng LIU,Ning GAO,Hua ZHU,Xiao-wei DAI,Lan HUANG,Ya-li LIU,Chun-mei MA,Chuan QIN

DOI: https://doi.org/10.3969/j.issn.1671-7856.2009.04.001

2009-01-01

Abstract:Objective To investigate the expression level of GRK5 in Parkinson's disease α-synuclein transgenic mouse model and elucidate the possible role of GRK5 in the pathogenesis of Parkinson's disease.Method The protein expression levels of GRK5 in various Parkinson's disease α-synuclein transgenic mice groups and 3-month,6-month and 9-month old A53T mutant mice were measured by Western blotting.Real time PCR was employed to detect the mRNA level of GRK5.GAPDH was used as an internal standard.Results The GRK5 protein level in Parkinson's disease α-synuclein transgenic mice was increased to different degrees compared with that in non-transgenic littermate control(NLC) mice,and the protein and mRNA expressions of GRK5 in 9-month old A53T mutant mice were higher than those in NLC mice,but there were no significant changes in the 3 month and 6 month old A53T mutant mice.Conclusion The expression level of GRK5 is elevated in Parkinson's disease α-synuclein transgenic mice.